<DOC>
	<DOCNO>NCT00106821</DOCNO>
	<brief_summary>The purpose study look benefit tiotropium , approve drug treatment bronchospasm associate COPD ( chronic obstructive pulmonary disease ) , population patient COPD African American descent .</brief_summary>
	<brief_title>Efficacy Tiotropium Patients African Descent With Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Male female African descent 40 year age old Diagnosis COPD History smoke least one pack per day least 10 year Currently experience shortness breath least exertion Asthma Recent myocardial infarction hospitalization congestive heart failure</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>